You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 6, June 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Successful Use of Cyclophosphamide and Prednisone for Initial Treatment of Pemphigus Vulgaris

Michael J. Fellner, MD; James M. Katz, MD; Jonathan B. McCabe

Arch Dermatol. 1978;114(6):889-894.


Abstract

• Previous reports showed that cyclophosphamide used late in the treatment of patients with pemphigus vulgaris reduced the complications due to steroids. In this study, cyclophosphamide was used in the initial treatment of five patients with pemphigus vulgaris in combination with prednisone to avoid side-effects of prednisone. Two patients had no prior treatment with steroids for pemphigus. Results indicate that the initial combined program may be a highly effective treatment method for pemphigus vulgaris. Followup from one to four years after treatment shows all five patients in remission; four require no medication.

(Arch Dermatol 114:889-894, 1978)



Author Affiliations

From the Department of Dermatology, Bird S. Coler Hospital, Roosevelt Island, NY, and New York Medical College, Flower and Fifth Avenue Hospital.


Footnotes

Accepted for publication Dec 2, 1977.

Reprint requests to Department of Dermatology, Bird S. Coler Hospital, Roosevelt Island, NY 10044 (Dr Fellner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris
Werth et al.
Arch Dermatol 2008;144:25-32.
ABSTRACT | FULL TEXT  

A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT | FULL TEXT  

PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT | FULL TEXT  

Therapy of Pemphigus Vulgaris
Stanley
Arch Dermatol 1999;135:76-78.
FULL TEXT  

The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT  

Treatment of Pemphigus Vulgaris With Pulse Intravenous Cyclophosphamide
Pandya and Sontheimer
Arch Dermatol 1992;128:1626-1630.
ABSTRACT  

Adjuvant Therapy of Pemphigus
Bystryn
Arch Dermatol 1984;120:941-951.
ABSTRACT  

Prednisolone Clearance: A Possible Determinant for Glucocorticoid Efficacy in Patients with Oral Vesiculo-erosive Diseases
Lozada et al.
JDR 1983;62:575-577.
ABSTRACT  

Pemphigus: Current Concepts
AHMED et al.
ANN INTERN MED 1980;92:396-405.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.